Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone

Free Radical Biology and Medicine

Volumn 22, Issue 1-2, 1997, Pages 11-16

  Bhattacharya, Mousumi ^a   Ponka, Premysl ^a   Hardy, Pierre ^b   Hanna, Nelly ^b   Varma, Daya R ^a   Lachapelle, Pierre ^a   Chemtob, Sylvain ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Asphyxia; Deteroxamine; Electroretinogram; Newborn; Peroxidation; Pyridoxal isonicotinoyl hydrazone; Retina

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; HYDROPEROXIDE; MALONALDEHYDE; PYRIDOXAL ISONICOTINOYLHYDRAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; ARTICLE; ASPHYXIA; CONTROLLED STUDY; ELECTRORETINOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0029859925     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00274-2     Document Type: Article

References (45)

1. Reddy B. R., Kloner R. A, Przyklenk K. Early treatment with desferrioxamine limits myocardial ischemic/reperfusion injury. Free Radic. Biol. Med. 7:1988;45-52.
2. Healing G., Gower J., Fuller B., Green C. Intracellular iron redistribution: An important determinant of reperfusion damage to rabbit kidneys. Biochem. Pharmacol. 39:1990;1239-1245.
3. Blake D. R., Gallagher P. J., Potter A. R., Bell M. J., Bacon P. A. The effect of synovial kiron on the progression of rheumatoid disease. Arthritis Rheum. 27:1984;495-501.
4. Biemond P., Swaak A. J. G., van Eijk H. G., Koster J. F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic. Biol. Med. 4:1988;185-198.
5. Ben-Shachar D., Riederer P., Youdim M. B. H. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 57:1989;1609-1614.
6. Halliwell B., Gutteridge J. M. C. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186:1990;1-85.
7. Hershko C. Iron chelators. Brock J. H., Halliday J. W., Pippard M. J., Powell L. W. Iron metabolism in health and disease. 1994;390-426 W. B Saunders Ltd, Philadelphia.
8. Buss J. L., Hasinoff B. B. Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (CRF-187). Arch. Biochem. Biophys. 317:1995;121.
9. Ponka P., Borova J., Neuwirt J., Fuchs O., Necas E. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents. Biochim. Biophys. Acta. 586:1979;278-297.
10. Cikrt M., Ponka P., Necas E., Neuwirt J. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone. Br. J. Haematol. 45:1980;275-283.
11. Johnson D. R., Pippard M. J., Murphy T. B., Rose N. J. An in vivo evaluation of iron-chelating drugs derived from pyridoxal and its analogues. J. Pharmacol. Exp. Ther. 221:1982;399-403.
12. Schulman H. M., Hermes-Lima M., Wang E. M., Ponka P. In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs. Redox Rep. 1:1995;373-378.
13. Writting L. Lipid peroxidation in vivo. J. Am. Oil Chem. Soc. 73:1965;1706-1710.
14. Anderson R., Benorhen R. Polyunsaturated fatty acids of photoreceptor membranes. Exp. Eye. Res. 18:1974;205-213.
15. Oliver P. D., Newsome D. A. Mitochondrial superoxide dismutase in mature and developing human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 33:1992;1909-1918.
16. Ophir A., Berenshtein E., Kitrossky N., Averbukh E. Protection of the transiently ischemic cat retina by zinc-desferrioxamine. Investig. Ophthalmol. Vis. Sci. 35:1994;1212-1222.
17. Gehlbach P. L., Purple R. L., Hallaway P. E., Hedlund B. E. Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model. Invest. Ophthalmol. Vis. Sci. 34:1993;2871-2877.
18. Chemtob S., Roy M., Abran D., Fernandez H., Varma D. Prevention of postasphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatr. Res. 33:1993;336-340.
19. Gunn T. R., Eastdown J., Outerbridge E. W., Aranda J. V. Risk factors in retrolental fibroplasia. Pediatrics. 65:1980;1096-1100.
20. Reynaud X., Hansen R. M., Fulton A. B. Effect of prior oxygen exposure on the electroretinographic response of infant rats. Invest. Ophthalmol. Vis. Sci. 36:1995;2071-2079.
21. Beauchemin M. L., Babel J. Proceedings: A preliminary study on the ultrastructure of the pig retina. Exp. Eye Res. 17:1973;400.
22. Bloodworth J. M. Jr., Gutgesall H. P. Jr., Engerman R. L. Retinal vasculature of the pig. Light and electron microscope studies. Exp. Eye Res. 4:1965;174-178.
23. Brittenham G. M. Pyridoxal isonicotinoyl hydrazone: An effective iron-chelator after oral administration. Semin. Hematol. 27:1990;112-116.
24. Fishman G. A. The electroretinogram in retinal disease. Fishman G. A., Sokol S. Electrophysiological testing in disorders of the retina, optic nerve, and visual pathways. 1990;1-91 American Academy of Ophthalmology, San Francisco.
25. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72:1976;248-254.
26. Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
27. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids. 26:1991;853-856.
28. Benson E. L. Electrical phenomenon in the retina. Hart W. M Jr. Adler's physiology of the eye. 1992;641-708 Mosby-Year Book, St. Louis, MO.
29. Castrén J. A., Toivakka E., Rantanen A. Bioelectrical findings in retrolental fibroplasia. Ann. Paediatr. Fenn. 13:1967;28-34.
30. Hoy T., Humphreys J., Jacobs A., Williams A., Ponka P. Effective iron chelation following oral administration of an isoniazid-pyridoxal hydrazone. Br. J. Haematol. 43:1979;443-449.
31. Richardson D. R., WIS vitolo M. L., Hefter G. T., May P. M., Clare B. W., Webb J., Wilairat P. Iron chelators of the pyridoxal isonicotinoyl hydrazone class: Part 1 ionisation characteristics of the ligands and their relevance to biological properties. Inorganic Chim. Acta. 170:1990;165-170.
32. Shvedova A. A., Sidorov A., Novkov K. N., Galvshchenko I. V., Kagan V. E. Lipid peroxidation and electrical activity of the retina. Vision Res. 19:1979;49-55.
33. Anderson R. E., Sperling L. Lipids of ocular tissues: VII. Positional distribution of the fatty acids in the phospholipids of bovine retina rod outer segments. Arch. Biochem. Biophys. 144:1971;673-677.
34. Palmer C., Roberts R. L., Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 25:1994;1039-1045.
35. Blake D. R., Winyard P., Lunec J. Cerebral and ocular toxicity induced by deferoxamine. Q. J. Med. New Series. 219:1985;345-355.
36. Olivieri N. F., Buncic J. R., Chew E., Gallant T., Harrison R. V., Keenan N., Logan W., Mitchell D., Ricci G., Skarf B., Taylor M., Freedman M. H. Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions. N. Engl. J. Med. 314:1986;869-873.
37. Davies S. C., Hungerford J. L., Arden G. B., Marcus R. E., Miller M. H., Heuhns E. R. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet. 2:1983;181-184.
38. Porter J. B., Huehns E. R. The toxic effects of desferrioxamine. Ballier Clin. Haematol. 2:1989;459-474.
39. Goplerud J. M., Mishra O. P., Papadopoulos M. D. Brain cell membrane dysfunction following acute asphyxia in newborn piglets. Biol. Neonate. 61:1992;33-41.
40. Fesenko E. E., Kolesnikov S. S., Lyubarsky A. L. Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment. Nature. 313:1985;310.
41. Aronson J. K. Potassium channels in nervous tissue. Biochem. Pharmacol. 43:1992;11-14.
42. Somjen G. G., Aitken P. G., Czeh G., Jing J., Young J. N. Cellular physiology of hypoxia of the mammalian central nervous system. Res. Publicat. Assoc. Res. Nervous Mental Dis. 71:1993;51-65.
43. 2+)-ATPase by nonheme iron. Biochim. Biophys. Acta. 1062:1991;35-38.
44. Ozaki M., Aoki S., Masuda Y. K(+)-linked release of oxidized glutathione induced by tert-butyl hydroperoxide in perfused rat liver is independent of lipid peroxidation and cell death. Jpn. J. Pharmocol. 65:1994;183-191.
45. Davis J. W., Petry T. W. Inhibition of S-(1,2-dichlorovinyl)-L-cysteine-induced lipid peroxidation by antioxidants in rabbit renal cortical slices: Dissociation of lipid peroxidation and toxicity. J. Biochem. Toxicol. 9:1994;121-130.